These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24408324)

  • 1. Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assay.
    Lordkipanidzé M; Lowe GC; Kirkby NS; Chan MV; Lundberg MH; Morgan NV; Bem D; Nisar SP; Leo VC; Jones ML; Mundell SJ; Daly ME; Mumford AD; Warner TD; Watson SP;
    Blood; 2014 Feb; 123(8):e11-22. PubMed ID: 24408324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical multichannel (optimul) platelet aggregometry in 96-well plates as an additional method of platelet reactivity testing.
    Chan MV; Armstrong PC; Papalia F; Kirkby NS; Warner TD
    Platelets; 2011; 22(7):485-94. PubMed ID: 21806492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study assessing the implementation of 96-well plate-based aggregometry (Optimul) in Australia.
    Hsu H; Chan MV; Armstrong PC; Crescente M; Donikian D; Kondo M; Brighton T; Chen V; Chen Q; Connor D; Joseph J; Morel-Kopp MC; Stevenson WS; Ward C; Warner TD; Rabbolini DJ
    Pathology; 2022 Oct; 54(6):746-754. PubMed ID: 35750510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simplified flow cytometric method for detection of inherited platelet disorders-A comparison to the gold standard light transmission aggregometry.
    Navred K; Martin M; Ekdahl L; Zetterberg E; Andersson NG; Strandberg K; Norstrom E
    PLoS One; 2019; 14(1):e0211130. PubMed ID: 30673773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Evaluation of Platelet Function With T2 Magnetic Resonance.
    Cuker A; Husseinzadeh H; Lebedeva T; Marturano JE; Massefski W; Lowery TJ; Lambert MP; Abrams CS; Weisel JW; Cines DB
    Am J Clin Pathol; 2016 Dec; 146(6):681-693. PubMed ID: 28028118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of multiple electrode aggregometry with lumi-aggregometry for the diagnosis of patients with mild bleeding disorders.
    Al Ghaithi R; Drake S; Watson SP; Morgan NV; Harrison P
    J Thromb Haemost; 2017 Oct; 15(10):2045-2052. PubMed ID: 28762630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet function testing: dead or alive.
    Helten C; Naguib D; Dannenberg L; Pöhl M; Ayhan A; Hohlfeld T; Levkau B; Kelm M; Zeus T; Polzin A
    J Thromb Haemost; 2018 May; 16(5):984-986. PubMed ID: 29512292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel.
    Dawood BB; Lowe GC; Lordkipanidzé M; Bem D; Daly ME; Makris M; Mumford A; Wilde JT; Watson SP
    Blood; 2012 Dec; 120(25):5041-9. PubMed ID: 23002116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of light transmission platelet aggregometry: results from a prospective study of individuals referred for bleeding disorder assessments.
    Hayward CP; Pai M; Liu Y; Moffat KA; Seecharan J; Webert KE; Cook RJ; Heddle NM
    J Thromb Haemost; 2009 Apr; 7(4):676-84. PubMed ID: 19143930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a high-throughput ELISA assay for platelet function testing using platelet-rich plasma or whole blood.
    Salles I; Broos K; Fontayne A; Szántó T; Ruan C; Nurden AT; Vanhoorelbeke K; Deckmyn H
    Thromb Haemost; 2010 Aug; 104(2):392-401. PubMed ID: 20508902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of light transmission aggregometry and multiple electrode aggregometry for the evaluation of patients with mucocutaneous bleeding.
    Sun P; McMillan-Ward E; Mian R; Israels SJ
    Int J Lab Hematol; 2019 Feb; 41(1):133-140. PubMed ID: 30358923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.
    Lordkipanidzé M; Pharand C; Schampaert E; Turgeon J; Palisaitis DA; Diodati JG
    Eur Heart J; 2007 Jul; 28(14):1702-8. PubMed ID: 17569678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of flow cytometric analysis of platelet function in patients with a suspected platelet function defect.
    van Asten I; Schutgens REG; Baaij M; Zandstra J; Roest M; Pasterkamp G; Huisman A; Korporaal SJA; Urbanus RT
    J Thromb Haemost; 2018 Apr; 16(4):689-698. PubMed ID: 29337406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric analysis of platelet function to improve the recognition of thrombocytopathy.
    Huskens D; Li L; Florin L; de Kesel P; de Laat B; Roest M; Devreese KMJ
    Thromb Res; 2020 Oct; 194():183-189. PubMed ID: 32788114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating platelet function disorders in children with bleeding tendency - A single center study.
    Tanous O; Steinberg Shemer O; Yacobovich J; Zoldan M; Horovitz Y; Yaniv I; Rabizadeh E; Tamary H; Nakav S; Lahav J
    Platelets; 2017 Nov; 28(7):676-681. PubMed ID: 28060550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of platelet function on the routine coagulation analyzer Sysmex CS-2000i.
    Frère C; Kobayashi K; Dunois C; Amiral J; Morange PE; Alessi MC
    Platelets; 2018 Jan; 29(1):95-97. PubMed ID: 28960123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet dysfunction caused by a novel thromboxane A
    Bugert P; Fischer L; Althaus K; Knöfler R; Bakchoul T
    Platelets; 2020; 31(2):276-279. PubMed ID: 31389738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to antiplatelet therapy is independent of endogenous thrombin generation potential.
    Gremmel T; Panzer S; Steiner S; Seidinger D; Koppensteiner R; Pabinger I; Kopp CW; Ay C
    Thromb Res; 2013 Jul; 132(1):e24-30. PubMed ID: 23623170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of platelet function in patients with chronic kidney disease stages IV-V.
    Khalid A; White D; Sharp M; Duff E; MacDonald S; Fry A; Thomas W
    Int J Lab Hematol; 2021 Dec; 43(6):1606-1611. PubMed ID: 34288455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel thromboxane A2 receptor N42S variant results in reduced surface expression and platelet dysfunction.
    Nisar SP; Lordkipanidzé M; Jones ML; Dawood B; Murden S; Cunningham MR; Mumford AD; Wilde JT; Watson SP; Mundell SJ; Lowe GC;
    Thromb Haemost; 2014 May; 111(5):923-32. PubMed ID: 24452735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.